| scholarly article | Q13442814 |
| P356 | DOI | 10.4065/78.2.147 |
| P698 | PubMed publication ID | 12583525 |
| P50 | author | Sergey I Tkachev | Q57612227 |
| P2093 | author name string | Alexey D Ryjkov | |
| Benjamin Y Bokhian | |||
| Gennady N Machak | |||
| Natalya V Kochergina | |||
| Pavel A Sinyukov | |||
| Stanislav M Ivanov | |||
| Valeria V Glebovskaya | |||
| Valery V Tepliakov | |||
| Yuriy N Solovyev | |||
| P433 | issue | 2 | |
| P921 | main subject | neoadjuvant chemotherapy | Q108855558 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 147-155 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities | |
| P478 | volume | 78 |
| Q93177633 | A prospective Phase II study for the efficacy of radiotherapy in combination with zoledronic acid in treating painful bone metastases from gastrointestinal cancers |
| Q37152000 | Bone tumors in adolescents and young adults |
| Q34662423 | Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223. |
| Q44582217 | Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma |
| Q33785368 | Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma |
| Q38161735 | Current therapeutic strategies and novel approaches in osteosarcoma |
| Q33383964 | Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma |
| Q47375034 | EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment |
| Q36623353 | Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives |
| Q42666099 | Malignant transformation of a high-grade osteoblastoma of the petrous apex with subcutaneous metastasis |
| Q36619766 | Management of osteosarcoma |
| Q49189268 | Methotrexate Free Chemotherapy and Limb Salvage Surgery for Paediatric Osteosarcoma in India |
| Q36718644 | Novel therapeutic approaches in pediatric and young adult sarcomas |
| Q47106888 | Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors. |
| Q37026245 | Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma |
| Q85242184 | Radiotherapy in the Treatment of Primary Osteosarcoma – a Single Center Experience |
| Q39037377 | Repair of radiation damage of U2OS osteosarcoma cells is related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity |
| Q64121884 | Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study |
| Q36514299 | The Current and Future Therapies for Human Osteosarcoma |
| Q91738997 | The inhibitory effects of cisplatin-radiation combination treatment on malignant osteosarcoma MG-63 cells and BRCA1-p53 pathways are more efficient than single treatments |
| Q37400016 | The multidisciplinary management of osteosarcoma |
| Q36277346 | Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. |
| Q36724338 | Tumours of the hand |
| Q34496992 | UK Guidelines for the Management of Bone Sarcomas |
| Q38399046 | Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience. |
| Q33884881 | WEE1 inhibition sensitizes osteosarcoma to radiotherapy |
| Q37688626 | Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma |
Search more.